Announcements

T. Rowe Price Investment Management, Inc. filed a Schedule 13G with the SEC on November 6, 2026, disclosing a 14.2% beneficial ownership position in MSG Rangers Corp common stock as of October 31, 2026.

GS Finance Corp. filed a Free Writing Prospectus on November 6, 2026, disclosing terms for Market Linked Securities that are auto-callable with a fixed coupon and contingent downside, linked to the lowest performing of three major equity indexes and due November 19, 2029.

T. Rowe Price Investment Management, Inc. filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of 7,905,757 shares of Xenon Pharmaceuticals Inc. common stock as of September 30, 2026.

T. Rowe Price Investment Management, Inc. filed Amendment No. 2 to Schedule 13G with the SEC on November 6, 2026, disclosing a 9.6% beneficial ownership position in Vaxcyte Inc. common stock as of September 30, 2026.

Orbis Investment Management Ltd and Orbis Investment Management (U.S.), L.P. filed a Schedule 13G Amendment No. 2 on November 6, 2026, disclosing a combined beneficial ownership of 4,421,602 shares of FirstService Corp common stock as of October 31, 2026.

Elong Power Holding Limited filed a Form 6-K on November 6, 2026, disclosing an inducement offer letter agreement entered into on November 5, 2026, under which certain warrant holders agreed to partially exercise existing warrants, generating gross proceeds of $3,255,845.40 for the company.

James P. Chiaro, EVP and Chief Investment Services Officer of Peoples Financial Services Corp., filed a Form 4 on November 6, 2026, disclosing a sale of 605 shares of common stock on November 4, 2026.